{"disease":{"id":"seminoma","name":"seminoma"},"drugs":{"marketed":[{"drug_id":"dactinomycin","indication_name":"Metastatic Nonseminomatous Testicular Cancer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cosmegen","generic_name":"DACTINOMYCIN","company_name":"Recordati","drug_phase":"marketed","molecular_target":"DNA","drug_class":"Actinomycin [EPC]","quality_score":65,"revenue":null,"mechanism":"Dactinomycin binds DNA and inhibits RNA synthesis, demonstrating cytotoxic activity in cancer models."}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03067181","title":"Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":1780,"lead_sponsor_name":"Children's Oncology Group","has_results":false},{"nct_id":"NCT04435756","title":"A Study of miRNA 371 in Patients With Germ Cell Tumors","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":956,"lead_sponsor_name":"SWOG Cancer Research Network","has_results":false},{"nct_id":"NCT01434355","title":"DNA Analysis in Samples From Younger Patients With Germ Cell Tumors and Their Parents or Siblings","phase":"","overall_status":"COMPLETED","enrollment_count":932,"lead_sponsor_name":"Children's Oncology Group","has_results":false},{"nct_id":"NCT02834013","title":"Nivolumab and Ipilimumab in Treating Patients With Rare Tumors","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":818,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT06967961","title":"Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers","phase":"NA","overall_status":"RECRUITING","enrollment_count":450,"lead_sponsor_name":"Institut Claudius Regaud","has_results":false},{"nct_id":"NCT02375204","title":"Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients with Relapsed or Refractory Germ Cell Tumors","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":420,"lead_sponsor_name":"Alliance for Clinical Trials in Oncology","has_results":false},{"nct_id":"NCT05108298","title":"Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials","phase":"NA","overall_status":"RECRUITING","enrollment_count":400,"lead_sponsor_name":"Eastern Cooperative Oncology Group","has_results":false},{"nct_id":"NCT04914026","title":"MicroRNA as Markers in Testicular Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":350,"lead_sponsor_name":"Haukeland University Hospital","has_results":false},{"nct_id":"NCT07498959","title":"Primary RPLND Versus Systemic Chemotherapy in Good-prognosis Metastatic Testicular Cancer","phase":"NA","overall_status":"RECRUITING","enrollment_count":160,"lead_sponsor_name":"Sahlgrenska University Hospital","has_results":false},{"nct_id":"NCT03937843","title":"Reduced Intensity Radio-chemotherapy for Stage IIA/B Seminoma","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":135,"lead_sponsor_name":"Swiss Cancer Institute","has_results":false},{"nct_id":"NCT01593241","title":"Therapy De-escalation in Seminoma Stage IIA/B","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":120,"lead_sponsor_name":"Swiss Cancer Institute","has_results":false},{"nct_id":"NCT02104986","title":"A Multicenter Study to Evaluate a Risk-adapted Strategy for Treatment of Extra Cranial Non Seminomateous Malignant Germ Cell Tumour in Children and Adolescent","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":117,"lead_sponsor_name":"Centre Leon Berard","has_results":false},{"nct_id":"NCT05529251","title":"De-escalation Study for Stage IIa/IIb < 3 cm Seminoma","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":90,"lead_sponsor_name":"Centre Leon Berard","has_results":false},{"nct_id":"NCT05142982","title":"Radiotherapy vs Observation for Post Chemotherapy Residual Mass in Advanced Seminoma","phase":"NA","overall_status":"RECRUITING","enrollment_count":74,"lead_sponsor_name":"Tata Memorial Centre","has_results":false},{"nct_id":"NCT06144736","title":"PRIMETEST II - Clinical Stage II A/B Seminoma Treated With RA-RPLND","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Heinrich-Heine University, Duesseldorf","has_results":false},{"nct_id":"NCT02537548","title":"Retroperitoneal Lymph Node Dissection in Treating Patients With Testicular Seminoma","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":55,"lead_sponsor_name":"University of Southern California","has_results":false},{"nct_id":"NCT02272816","title":"Carboplatin AUC-10 With Early PET Scanning in Metastatic Seminoma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"Barts & The London NHS Trust","has_results":true},{"nct_id":"NCT07218913","title":"Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":44,"lead_sponsor_name":"City of Hope Medical Center","has_results":false},{"nct_id":"NCT06133543","title":"Robot-assisted ICG-guided Sentinel Node Biopsy in Testicular Cancer","phase":"NA","overall_status":"RECRUITING","enrollment_count":44,"lead_sponsor_name":"Heinrich-Heine University, Duesseldorf","has_results":false},{"nct_id":"NCT02115165","title":"A Prospective Study of Cabazitaxel in Patients With Non Seminomatous Germ-cell Tumors","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":34,"lead_sponsor_name":"Gustave Roussy, Cancer Campus, Grand Paris","has_results":false},{"nct_id":"NCT06309745","title":"THERApy De-escalation for TESTicular Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Queen Mary University of London","has_results":false},{"nct_id":"NCT01055067","title":"ARQ 197 for Participants With Relapsed or Refractory Germ Cell Tumors","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":27,"lead_sponsor_name":"Daiichi Sankyo","has_results":true},{"nct_id":"NCT00638898","title":"Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"City of Hope Medical Center","has_results":false},{"nct_id":"NCT02689219","title":"Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":18,"lead_sponsor_name":"Nabil Adra","has_results":true},{"nct_id":"NCT05634785","title":"CD30 CAR for CD30+ NSGCT","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":2,"lead_sponsor_name":"UNC Lineberger Comprehensive Cancer Center","has_results":false}],"total":25},"guidelines":[],"source":"Drug Landscape verified database"}